Figure 3

GDF-15 levels do not decrease over time in the absence of treatment. Development of serum GDF-15 over 28 months in treated patients (black lines) from group 2 versus untreated patients (P25 and P26, red lines).
GDF-15 levels do not decrease over time in the absence of treatment. Development of serum GDF-15 over 28 months in treated patients (black lines) from group 2 versus untreated patients (P25 and P26, red lines).